Report Detail
Global mRNA Cancer Vaccines and Therapeutics Market 2025 by Company, Regions, Type and Application, Forecast to 2031
- RnM4656444 |
- 05 December, 2025 |
- Global |
- 88 Pages |
- GIR |
- Other
According to our (Global Info Research) latest study, the global mRNA Cancer Vaccines and Therapeutics market size was valued at US$ 204 million in 2024 and is forecast to a readjusted size of USD 663 million by 2031 with a CAGR of 18.6% during review period.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
This report is a detailed and comprehensive analysis for global mRNA Cancer Vaccines and Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global mRNA Cancer Vaccines and Therapeutics market size and forecasts, in consumption value ($ Million), 2020-2031
Global mRNA Cancer Vaccines and Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global mRNA Cancer Vaccines and Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global mRNA Cancer Vaccines and Therapeutics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Cancer Vaccines and Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Cancer Vaccines and Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
mRNA Cancer Vaccines and Therapeutics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
Market segment by Application
Infectious Disease
Cancer
Others
Market segment by players, this report covers
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe mRNA Cancer Vaccines and Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Cancer Vaccines and Therapeutics, with revenue, gross margin, and global market share of mRNA Cancer Vaccines and Therapeutics from 2020 to 2025.
Chapter 3, the mRNA Cancer Vaccines and Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and mRNA Cancer Vaccines and Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Cancer Vaccines and Therapeutics.
Chapter 13, to describe mRNA Cancer Vaccines and Therapeutics research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of mRNA Cancer Vaccines and Therapeutics by Type
- 1.3.1 Overview: Global mRNA Cancer Vaccines and Therapeutics Market Size by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Type in 2024
- 1.3.3 Adeno Carcinomas
- 1.3.4 Mucinous Carcinomas
- 1.3.5 Adenosquamous Carcinomas
- 1.4 Global mRNA Cancer Vaccines and Therapeutics Market by Application
- 1.4.1 Overview: Global mRNA Cancer Vaccines and Therapeutics Market Size by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Infectious Disease
- 1.4.3 Cancer
- 1.4.4 Others
- 1.5 Global mRNA Cancer Vaccines and Therapeutics Market Size & Forecast
- 1.6 Global mRNA Cancer Vaccines and Therapeutics Market Size and Forecast by Region
- 1.6.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
- 1.6.2 Global mRNA Cancer Vaccines and Therapeutics Market Size by Region, (2020-2031)
- 1.6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
- 1.6.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
- 1.6.5 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
- 1.6.6 South America mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
- 1.6.7 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size and Prospect (2020-2031)
2 Company Profiles
- 2.1 Moderna Therapeutics
- 2.1.1 Moderna Therapeutics Details
- 2.1.2 Moderna Therapeutics Major Business
- 2.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
- 2.1.4 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Moderna Therapeutics Recent Developments and Future Plans
- 2.2 CureVac
- 2.2.1 CureVac Details
- 2.2.2 CureVac Major Business
- 2.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Product and Solutions
- 2.2.4 CureVac mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 CureVac Recent Developments and Future Plans
- 2.3 Translate Bio
- 2.3.1 Translate Bio Details
- 2.3.2 Translate Bio Major Business
- 2.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Product and Solutions
- 2.3.4 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Translate Bio Recent Developments and Future Plans
- 2.4 BioNTech
- 2.4.1 BioNTech Details
- 2.4.2 BioNTech Major Business
- 2.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Product and Solutions
- 2.4.4 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 BioNTech Recent Developments and Future Plans
- 2.5 Sangamo Therapeutics
- 2.5.1 Sangamo Therapeutics Details
- 2.5.2 Sangamo Therapeutics Major Business
- 2.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
- 2.5.4 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Sangamo Therapeutics Recent Developments and Future Plans
- 2.6 Argos Therapeutics
- 2.6.1 Argos Therapeutics Details
- 2.6.2 Argos Therapeutics Major Business
- 2.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product and Solutions
- 2.6.4 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Argos Therapeutics Recent Developments and Future Plans
- 2.7 In-Cell-Art
- 2.7.1 In-Cell-Art Details
- 2.7.2 In-Cell-Art Major Business
- 2.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product and Solutions
- 2.7.4 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 In-Cell-Art Recent Developments and Future Plans
- 2.8 eTheRNA
- 2.8.1 eTheRNA Details
- 2.8.2 eTheRNA Major Business
- 2.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Product and Solutions
- 2.8.4 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 eTheRNA Recent Developments and Future Plans
- 2.9 Ethris
- 2.9.1 Ethris Details
- 2.9.2 Ethris Major Business
- 2.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Product and Solutions
- 2.9.4 Ethris mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Ethris Recent Developments and Future Plans
- 2.10 Tiba Biotechnology
- 2.10.1 Tiba Biotechnology Details
- 2.10.2 Tiba Biotechnology Major Business
- 2.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product and Solutions
- 2.10.4 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 Tiba Biotechnology Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global mRNA Cancer Vaccines and Therapeutics Revenue and Share by Players (2020-2025)
- 3.2 Market Share Analysis (2024)
- 3.2.1 Market Share of mRNA Cancer Vaccines and Therapeutics by Company Revenue
- 3.2.2 Top 3 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2024
- 3.2.3 Top 6 mRNA Cancer Vaccines and Therapeutics Players Market Share in 2024
- 3.3 mRNA Cancer Vaccines and Therapeutics Market: Overall Company Footprint Analysis
- 3.3.1 mRNA Cancer Vaccines and Therapeutics Market: Region Footprint
- 3.3.2 mRNA Cancer Vaccines and Therapeutics Market: Company Product Type Footprint
- 3.3.3 mRNA Cancer Vaccines and Therapeutics Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Value and Market Share by Type (2020-2025)
- 4.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
- 5.1 Global mRNA Cancer Vaccines and Therapeutics Consumption Value Market Share by Application (2020-2025)
- 5.2 Global mRNA Cancer Vaccines and Therapeutics Market Forecast by Application (2026-2031)
6 North America
- 6.1 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
- 6.2 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2031)
- 6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country
- 6.3.1 North America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2031)
- 6.3.2 United States mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 6.3.3 Canada mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 6.3.4 Mexico mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
7 Europe
- 7.1 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
- 7.2 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2031)
- 7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country
- 7.3.1 Europe mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2031)
- 7.3.2 Germany mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 7.3.3 France mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 7.3.4 United Kingdom mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 7.3.5 Russia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 7.3.6 Italy mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
8 Asia-Pacific
- 8.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
- 8.2 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2031)
- 8.3 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Market Size by Region
- 8.3.1 Asia-Pacific mRNA Cancer Vaccines and Therapeutics Consumption Value by Region (2020-2031)
- 8.3.2 China mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 8.3.3 Japan mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 8.3.4 South Korea mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 8.3.5 India mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 8.3.6 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 8.3.7 Australia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
9 South America
- 9.1 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
- 9.2 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2031)
- 9.3 South America mRNA Cancer Vaccines and Therapeutics Market Size by Country
- 9.3.1 South America mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2031)
- 9.3.2 Brazil mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 9.3.3 Argentina mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
10 Middle East & Africa
- 10.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Type (2020-2031)
- 10.2 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Application (2020-2031)
- 10.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country
- 10.3.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Consumption Value by Country (2020-2031)
- 10.3.2 Turkey mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 10.3.3 Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
- 10.3.4 UAE mRNA Cancer Vaccines and Therapeutics Market Size and Forecast (2020-2031)
11 Market Dynamics
- 11.1 mRNA Cancer Vaccines and Therapeutics Market Drivers
- 11.2 mRNA Cancer Vaccines and Therapeutics Market Restraints
- 11.3 mRNA Cancer Vaccines and Therapeutics Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 mRNA Cancer Vaccines and Therapeutics Industry Chain
- 12.2 mRNA Cancer Vaccines and Therapeutics Upstream Analysis
- 12.3 mRNA Cancer Vaccines and Therapeutics Midstream Analysis
- 12.4 mRNA Cancer Vaccines and Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on mRNA Cancer Vaccines and Therapeutics. Industry analysis & Market Report on mRNA Cancer Vaccines and Therapeutics is a syndicated market report, published as Global mRNA Cancer Vaccines and Therapeutics Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of mRNA Cancer Vaccines and Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
